We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIS icon
3401
iShares MSCI Israel ETF
EIS
$909M
$23.3K ﹤0.01%
400
AKO.A icon
3402
Embotelladora Andina Series A
AKO.A
$3.78B
$22.8K ﹤0.01%
1,753
SLND icon
3403
Southland Holdings
SLND
$31.4M
$22.1K ﹤0.01%
4,294
+195
+5% +$1.12K
ORTX
3404
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$21.7K ﹤0.01%
1,318
+1,176
+828% +$18.5K
BLZE icon
3405
Backblaze
BLZE
$1.16B
$21.5K ﹤0.01%
2,833
NAAS
3406
NaaS Technology Inc
NAAS
$59M
$20.9K ﹤0.01%
43
-7
-14% -$5.7K
KC
3407
Kingsoft Cloud Holdings
KC
$3.69B
$20.8K ﹤0.01%
5,505
-95
-2% -$434
TUYA
3408
Tuya Inc
TUYA
$1.1B
$20.5K ﹤0.01%
8,925
MTLS
3409
Materialise
MTLS
$396M
$20.4K ﹤0.01%
3,103
OZON
3410
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$20.3K ﹤0.01%
1,750
CAN
3411
Canaan Creative
CAN
$159M
$20.2K ﹤0.01%
8,748
MESO
3412
Mesoblast
MESO
$2.07B
$20K ﹤0.01%
9,077
+410
+5% +$978
AC
3413
DELISTED
Associated Capital Group
AC
$19.6K ﹤0.01%
549
CNTB
3414
Connect Biopharma Holdings
CNTB
$139M
$19.5K ﹤0.01%
16,520
TWIN icon
3415
Twin Disc
TWIN
$348M
$19.4K ﹤0.01%
1,200
RAIN
3416
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$19.2K ﹤0.01%
16,007
-2,310
-13% -$2.49K
CRGE
3417
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$19.1K ﹤0.01%
167,902
+10,000
+6% +$2.72K
RERE
3418
ATRenew
RERE
$1.01B
$18.9K ﹤0.01%
9,865
-9,275
-48% -$16.3K
LWAY icon
3419
Lifeway Foods
LWAY
$481M
$18.8K ﹤0.01%
1,400
INVE icon
3420
Identive
INVE
$61.9M
$18.7K ﹤0.01%
2,270
TSBX
3421
DELISTED
Turnstone Biologics
TSBX
$18.4K ﹤0.01%
7,241
-589
-8% -$1.54K
GPCR icon
3422
Structure Therapeutics
GPCR
$3.78B
$18.3K ﹤0.01%
+450
New +$25.8K
HURC icon
3423
Hurco Companies Inc
HURC
$143M
$18.1K ﹤0.01%
843
AVDL
3424
DELISTED
Avadel Pharmaceuticals
AVDL
$17.7K ﹤0.01%
1,256
ESTA icon
3425
Establishment Labs
ESTA
$2.28B
$17.7K ﹤0.01%
682

Similar funds

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.